Interventional Neurology Devices and Equipment Market Report 2026

The interventional neurology devices and equipment market size has grown strongly in recent years. It will grow from $2.45 billion in 2025 to $2.64 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising incidence of stroke and cerebral aneurysms, expansion of specialized neurology centers, increased awareness of endovascular treatments, advancements in microcatheter technologies, improvements in imaging systems.

The interventional neurology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $3.72 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing demand for advanced stroke management solutions, rising adoption of AI-supported neuroimaging, expansion of comprehensive stroke centers, growing focus on early intervention protocols, increasing investments in neurovascular innovation. Major trends in the forecast period include increasing adoption of neurothrombectomy devices, rising use of flow diversion and embolization technologies, growing integration of image-guided neurointerventions, expansion of minimally invasive stroke treatments, enhanced focus on rapid intervention outcomes.

The increasing prevalence of neurological disorders is expected to drive growth in the interventional neurology devices market. Disorders such as Alzheimer's disease, cerebrovascular diseases including stroke, migraine, and other headache disorders are becoming more common. Factors contributing to this rise include the growing geriatric population, high stress levels among younger individuals, and head injuries from accidents. For example, the Brain Aneurysm Foundation, a US-based organization focused on brain aneurysm awareness, estimates that 6 million people in the United States suffer from unruptured brain aneurysms. Additionally, according to the World Health Organization, over 50 million people worldwide have epilepsy, and more than 47 million are affected by dementia. Consequently, the rising prevalence of neurological disorders is expected to propel growth in the interventional neurology devices market.

The growing demand for minimally invasive treatments is also driving market expansion. Minimally invasive procedures aim to achieve diagnostic or therapeutic outcomes while minimizing disruption to the body’s tissues and structures. These approaches are increasingly preferred for treating neurological disorders, as interventional neurology devices offer safer, more effective, and less disruptive options for patients. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit professional organization, reported that total surgical and non-surgical procedures increased by 3.4% in 2023, reaching 34.9 million, driven by a 5.5% rise in surgical procedures. Plastic surgeons performed over 15.8 million surgical procedures and 19.1 million non-surgical procedures, representing a 40% overall increase over four years. This growing preference for minimally invasive treatments is supporting the expansion of the interventional neurology devices market.

Companies in the market are also developing innovative solutions to enhance treatment options. One example is SenTiva DUO, a new implantable pulse generator (IPG) with a dual-pin header that delivers vagus nerve stimulation (VNS) therapy for patients with drug-resistant epilepsy who were previously unable to access the latest VNS treatments. Launched in February 2023 by LivaNova Plc., a UK-based medical device company, SenTiva DUO offers several advantages over the original device, including a smaller size, longer battery life, and compatibility with dual-pin leads, providing a valuable new treatment option for patients with drug-resistant epilepsy.

Major companies operating in the interventional neurology devices and equipment market are Medtronic plc, Stryker Corporation, Terumo Corporation, Penumbra Inc., COVIDien, Abbott Laboratories, Merit Medical Systems Inc., W. L. Gore & Associates, Bayer AG, MicroPort Scientific Corporation, Boston Scientific Corporation, Johnson & Johnson, Medikit Co. Ltd., Acandis GmbH, Biosensors International Ltd., Cook Group Incorporated, Siemens Healthineers, B. Braun Melsungen AG, Nihon Kohden Corporation, LivaNova, Teleflex Incorporated, Balt Extrusion SAS, Rapid Medical Ltd., phenox GmbH, Spiegelberg GmbH & Co. KG.

North America was the largest region in the global interventional neurology devices and equipment market in 2025. Asia-Pacific was the second-largest region in the interventional neurology devices and equipment market. The regions covered in the interventional neurology devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the interventional neurology devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

Tariffs are influencing the interventional neurology devices and equipment market by increasing costs of imported microcatheters, guidewires, coils, stents, imaging components, and navigation systems. Hospitals and neurology centers in North America and Europe are most affected due to dependence on high-precision imported devices, while Asia-Pacific experiences cost pressure on manufacturing and exports. These tariffs are raising procedure costs and impacting capital equipment planning. At the same time, they are encouraging local device manufacturing, regional R&D investments, and development of cost-optimized neurointerventional solutions.

The interventional neurology devices and equipment market research report is one of a series of new reports that provides interventional neurology devices and equipment market statistics, including interventional neurology devices and equipment industry global market size, regional shares, competitors with a interventional neurology devices and equipment market share, detailed interventional neurology devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the interventional neurology devices and equipment industry. This interventional neurology devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Interventional neurology devices and equipment play a critical role in the treatment of neurovascular diseases, including conditions such as aneurysms, arteriovenous malformations, cavernous malformations, and strokes.

The primary categories of interventional neurology devices and equipment include aneurysm coiling and embolization devices, cerebrospinal fluid management devices, neuro thrombectomy devices, and various support devices. Neuro thrombectomy devices are utilized for the mechanical removal of thrombi from intracranial arteries via angiographic procedures. Aneurysm coiling and embolization devices consist of embolic coils, flow diversion devices, and liquid embolic devices. The angioplasty device category includes carotid artery stents and embolic protection systems. Support devices encompass micro guidewires and microcatheters, while neurothrombectomy devices are further divided into clot retrieval devices, suction and aspiration devices, and snares. These devices find application in a range of healthcare settings, including hospitals, neurology clinics, ambulatory care centers, and others.

The interventional neurology devices and equipment market consists of sales of instruments such as carotid artery stents, embolic protection systems, micro guide wires, and micro catheters. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.